Industry / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Chagas Treatment Simplified For Cost And Dosage Related Issues
July 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
The Associated Press has reported that the Pharmaceutical Laboratory of Pernambuco will provide child-sized doses for Chagas disease, eliminating the need to divide adult-sized doses. Drugs for Neglected Diseases Initiative (DNDi), an independent non-profit organisation, helped develop the treatment after the Brazilian government received the rights for benznidazole from Roche .